echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > During the outbreak period, patients with chronic pulmonary resistance should not be expected

    During the outbreak period, patients with chronic pulmonary resistance should not be expected

    • Last Update: 2020-11-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    the outbreak of new crown pneumonia is still ongoing and should not be taken lightly, especially for some people with underlying diseases. A study published in The Lancet found that people with respiratory diseases, coronary heart disease, hypertension, diabetes and other diseases, if infected with the new coronavirus, easy to change from mild to severe, the death rate is higher. Among them, as a respiratory disease with low awareness, patients with chronic obstructive pulmonary disease (CALLEDP) should pay special attention.
    the outbreak has made many people realize that the human respiratory tract, which is connected to the outside world, is a more vulnerable part. The respiratory system is like a big tree, with trunks, branches and leaves; The air channel communicates with tens of thousands of liters of gas every day, so the lungs are susceptible to injury and respiratory diseases are more common.
    characteristic of the slow-blocking lung is that the respiratory air flow is restricted, causing a decrease in lung function. Air flow restrictions are induced, such as smoking, air pollution, dust, etc., which are risk factors for the formation of slow-blocking lungs. Among them, smoking is the most important risk factor of slow lung, whether active smoking or passive smoking (i.e. secondhand smoke). However, these risk factors will take a certain amount of time to develop. Therefore, the retardant lung also has a characteristic, the prevalence rate before the age of 40 is relatively low. At present, the prevalence of chronic lung disease in people aged 40 and over in China is 13.7%.
    because of its chronic progression process, the public does not pay enough attention to the slow-blocking lung and does not recognize and diagnose it in a timely manner in the early stages of the disease. Coughing, sputum, wheezing and breathing difficulties are the main clinical manifestations of slow-blocking lungs, and they are more likely to experience breathing difficulties and susceptible to wheezing and chest tightness when moving compared to their peers. However, care should be made to distinguish between slow-blocking lungs and asthma. Asthma and slow-blocking lung are respiratory diseases, and there is a lot of overlap in their clinical manifestations, both of which are coughing, wheezing, shortness of breath, but they are two different diseases. In the treatment results, after an asthma attack, after treatment lung function can return to normal, come fast, go fast. And slow-blocking lung, even if treated, can only reduce the injury, lung function back to the previous state is difficult.
    like coronary heart disease patients may have angina, heart infarction, retardant lung although chronic diseases, but in the external blow, may also be acute aggravation. At this time, the patient's condition is more obvious, in severe cases can appear respiratory failure, or even life-threatening. Infections are the leading cause of acute exacerbation of the PHOSP, including viral infections and bacterial infections. Therefore, it is recommended that patients with chronic pulmonary disease must be vaccinated against pneumococcal bacteria and influenza, so as to minimize the risk of these two pathogens and prevent them before they do, which is an important measure to reduce acute exacerbation. Of course, there are more and more pathogens, such as the current new coronavirus, to be completely prevented is unlikely, but the risk can be reduced by one point.
    the main cause of breathing difficulties in the slow-blocking lungs is poor airflow caused by inflammation of the airways, so the key to treatment is to open the airways. How do I open it? This is what is medically called bronchid dilation drug - bronchid dilation agent. There are two important subjects on the respiratory tract, one called beta 2, and one called choline energy, involved in the contraction and expansion of the bronchial tube. Twenty or thirty years ago, bronchid expanders were so short-lived that they worked only for two to four hours, and needed to be added again after four hours of use. Today's bronchid dilates can work longer, like hypertension drugs, and once a day is enough.
    tracheal dilation drug is known as the cornerstone of the treatment of tracheal dilation, meaning that the treatment of tracheal dilation drugs is generally preferred. Long-acting bronchial dilates have anticholinel energy drugs and beta 2-subjector astrists, both of which can open the air. Later, the study found that the two drugs used together were better than a single drug. As a result, there is a double expansion agent (double tracheal expander). At present, a total of three dual expansion agents have been listed in China, two of which have entered health insurance.
    , however, for patients with chronic pulmonary disease, rehabilitation requires full-cycle management, not just medication, but lifestyle changes. First, the impact of risk factors, such as not smoking and secondhand smoke, must be reduced, and masks should be worn in foggy environments. Second, do some physical activity within your power to exercise the strength of your breathing and skeletal muscles. Again, nutrition needs to be replenished, and the most important substance in muscle is protein, so patients need to eat enough protein to have the ingredients that are converted into muscle. Finally, also pay attention to emotional and psychological problems, slow-blocking lung has a high rate of disability, to daily life has a great impact, easy to lead to depression, patients must have confidence.
    period, patients with chronic pulmonary disease should do a good job of maintenance treatment. Even if infected with the new coronavirus, adhere to the standard management of the development of the disease will not be very fast. If the maintenance treatment of underlying diseases is not done well, the new coronavirus will become a trigger, easily leading to the patient from mild to severe, resulting in an increased risk of death.
    (Li Yanming and Wang Wei, Deputy Director of Respiratory and Critical Care Medicine and Director of Infection Department, Beijing Chaoyang Hospital, Respectively, Chief Physician of Respiratory and Critical Care Medicine Department)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.